Fast-growing Gilead buys an R&D campus for $135M — report; Eureka bags $60M round for T cell R&D work
→ Fresh off its deal to acquire Kite, the fast-growing biotech Gilead $GILD has just struck a deal to buy the old Agensys campus …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
